These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30540865)
1. [Survival of pediatric patients with Ewing sarcoma treated at Semmelweis University]. Geiszl Z; Kiss J; Szendrõi M; Vízkeleti J; Arató G; Sápi Z; Kriván G; Mohás A; Rényi I; Garami M; Hauser P Magy Onkol; 2018 Dec; 62(4):230-236. PubMed ID: 30540865 [TBL] [Abstract][Full Text] [Related]
2. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261 [TBL] [Abstract][Full Text] [Related]
3. Outcome of Ewing sarcoma in children and adolescents with Ewing sarcoma: a five-year survival from a single institution. Zawitkowska-Klaczyńska J; Drabko K; Katski K; Wozniak M; Kowalczyk JR Pediatr Hematol Oncol; 2004; 21(7):627-33. PubMed ID: 15626019 [TBL] [Abstract][Full Text] [Related]
4. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318 [TBL] [Abstract][Full Text] [Related]
5. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis. Martin E; Radomski S; Harley EH Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068 [TBL] [Abstract][Full Text] [Related]
6. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL; BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077 [TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722 [TBL] [Abstract][Full Text] [Related]
8. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group. Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763 [TBL] [Abstract][Full Text] [Related]
9. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma. Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186 [TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653 [TBL] [Abstract][Full Text] [Related]
13. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137 [TBL] [Abstract][Full Text] [Related]
14. Pelvis Ewing sarcoma: Local control and survival in the modern era. Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
16. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology. Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639 [TBL] [Abstract][Full Text] [Related]